Questions a plan sponsor actually asks.
What is Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, and Sodium Phosphate, Monobasic, used for?
Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, and Sodium Phosphate, Monobasic, is a this drug class medication tracked in Medicare Part D.
Is there a generic for Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, and Sodium Phosphate, Monobasic,?
No. Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, and Sodium Phosphate, Monobasic, is brand-only with no generic equivalents currently in market.
How much does my plan pay for Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, and Sodium Phosphate, Monobasic,?
Across 329 Part D plans, Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, and Sodium Phosphate, Monobasic, averages $9.43/unit (NADAC). Lowest available: $9.43/unit. Highest in distribution: $9.43/unit.
Is Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, and Sodium Phosphate, Monobasic, on the FDA shortage list?
No. Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, and Sodium Phosphate, Monobasic, is not currently on the FDA Drug Shortage Database.
3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.